NEW YORK, Aug. 28, 2018 (GLOBE NEWSWIRE) -- The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.
Rockwell Medical, Inc. (NASDAQ: RMTI)
Lead Plaintiff Deadline: September 25, 2018
Class Period: March 16, 2018 and June 26, 2018
Get additional information about RMTI: http://www.wongesq.com/pslra-c/rockwell-medical-inc?wire=3
Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH)
Lead Plaintiff Deadline: September 25, 2018
Class Period: (1) Pursuant and/or traceable to the July 2017 Secondary Offering and/or (2) between March 8, 2017 and February 13, 2018
Get additional information about TTPH: http://www.wongesq.com/pslra-c/tetraphase-pharmaceuticals-inc?wire=3
Nielsen Holdings plc (NYSE: NLSN)
Lead Plaintiff Deadline: October 9, 2018
Class Period: February 8, 2018 and July 25, 2018
Get additional information about NLSN: http://www.wongesq.com/pslra-c/nielsen-holdings-plc?wire=3
Tesla, Inc. (NASDAQ: TSLA)
Lead Plaintiff Deadline: October 9, 2018
Class Period: Purchasers of shares between August 7, 2018 and August 14, 2018 and/or who had open short positions or put options for Tesla as of August 7, 2018 or August 8, 2018
Get additional information about TSLA: http://www.wongesq.com/pslra-1/tesla-inc-loss-submission-form?wire=3
Pinduoduo Inc. (NASDAQ: PDD)
Lead Plaintiff Deadline: October 22, 2018
Class Period: Pursuant to the July 26, 2018 initial public offering
Get additional information about PDD: http://www.wongesq.com/pslra-1/pinduoduo-inc-loss-form?wire=3
Ampio Pharmaceuticals, Inc. (NYSEAmerican: AMPE)
Lead Plaintiff Deadline: October 24, 2018
Class Period: December 14, 2017 and August 7, 2018
Get additional information about AMPE: http://www.wongesq.com/pslra-1/ampio-pharmaceuticals-inc-loss-form?wire=3
Nevro Corp. (NYSE: NVRO)
Lead Plaintiff Deadline: October 22, 2018
Class Period: January 8, 2018 and July 12, 2018
Get additional information about NVRO: http://www.wongesq.com/pslra-1/nevro-corp-loss-submission-form?wire=3
To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com